Both in Biotechnology
Tessera Defense and Homeland Security vs AIM ImmunoTech
Over the past year HLSQ returned −86.5% and AIM returned −30.3%; their daily moves had a correlation of 0.12.
HLSQ −86.5% AIM −30.3%Growth of $1, one year, split-adjusted
| Metric | HLSQ | AIM |
|---|---|---|
| Price | $0.1718 | $0.1545 |
| Market cap | $3.5M | $6.2M |
| Today | −4.56% | −4.04% |
| 1 month | −55.4% | −17.7% |
| 6 months | — | −70.0% |
| Year to date | — | −86.3% |
| 1 year | — | −93.5% |
| Revenue growth (YoY) | — | +4.0% |
| Gross margin | — | 80.8% |
| Net margin | — | −26876.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 64.9× |
| Net cash | — | $6.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 70.1% |
| Short % of float | 3.6% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).